Description:
POPULATION/CONVENIENCE CONTROL
CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL
|
Repository
|
NINDS Repository
|
| Subcollection |
Control |
| Quantity |
20 µg |
| Quantitation Method |
Please see our FAQ |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
DNA from LCL
|
|
Race
|
White
|
|
Ethnicity
|
Not Hispanic/Latino
|
|
Country of Origin
|
USA
|
|
Family History
|
N
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
| Ferrari R, Mok K, Moreno JH, Cosentino S, Goldman J, Pietrini P, Mayeux R, Tierney MC, Kapogiannis D, Jicha GA, Murrell JR, Ghetti B, Wassermann EM, Grafman J, Hardy J, Huey ED, Momeni P, Screening for C9ORF72 repeat expansion in FTLD Neurobiology of aging33:1850.e1-11 2012 |
| PubMed ID: 22459598 |
| |
| Ferrari R, Moreno JH, Minhajuddin AT, O'Bryant SE, Reisch JS, Barber RC, Momeni P, Implication of common and disease specific variants in CLU, CR1, and PICALM Neurobiology of aging33:1846.e7-18 2011 |
| PubMed ID: 22402018 |
| Cumulative PDL at Freeze |
2 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|
|